3/31
02:13 am
nbtx
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025 [Yahoo! Finance]
High
Report
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025 [Yahoo! Finance]
3/31
02:00 am
nbtx
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
High
Report
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
3/27
04:15 pm
nbtx
Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
Low
Report
Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
3/20
04:41 pm
nbtx
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference [Yahoo! Finance]
Medium
Report
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference [Yahoo! Finance]
3/20
04:15 pm
nbtx
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Medium
Report
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
3/17
04:15 pm
nbtx
NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
High
Report
NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
3/13
05:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Medium
Report
Voting Rights and Shares Capital of the Company
2/19
06:31 am
nbtx
Nanobiotix S.A. (NASDAQ: NBTX) was upgraded by analysts at UBS Group AG to a "hold" rating.
Medium
Report
Nanobiotix S.A. (NASDAQ: NBTX) was upgraded by analysts at UBS Group AG to a "hold" rating.
2/14
11:49 am
nbtx
Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In? [Yahoo! Finance]
Low
Report
Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In? [Yahoo! Finance]
2/12
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Medium
Report
Voting Rights and Shares Capital of the Company
1/29
06:57 pm
nbtx
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025 [Yahoo! Finance]
Low
Report
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025 [Yahoo! Finance]
1/29
04:15 pm
nbtx
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
Low
Report
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
1/21
02:30 am
nbtx
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
Medium
Report
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
1/9
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Low
Report
Voting Rights and Shares Capital of the Company